The FDA’s database for drug approvals includes an Abbreviated New Drug Application (ANDA) numbered ANDA083639 submitted by Roche. The application covers the brand name ENDEP, an oral tablet formulation of amitriptyline hydrochloride.
The ANDA lists five product variants, each with a distinct strength—10 mg, 25 mg, 50 mg, 75 mg, and 100 mg. All five tablets are designated as “Discontinued” in marketing status, indicating they are no longer marketed.
法规动态2026年8月25日•1 分钟阅读
FDA Lists ENDEP Amitriptyline Tablet Products (ANDA083639)
FDA’s ANDA083639 lists five ENDEP oral amitriptyline tablets (10‑100 mg) from Roche, all marked discontinued.
由 PharmaCountry 团队整理 · 来源： FDA.gov
评分
(0)
(0)
(0)
(0)
(0)
留下您的评分